Search results
Apr 4, 2024 · Depending on the variant, symptoms develop 2-14 days after exposure and can last from several days to weeks. ... is a subvariant of BA. 2, which was the main Omicron variant. This variant only ...
1 day ago · A self-amplifying mRNA vaccine shows promise in this new modality by eliciting neutralizing antibodies against the SARS-CoV-2 Omicron (BA.1) variant in a phase 2/3 trial.
Mar 27, 2024 · Background The prevalence and distinction between first Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and reinfection with the Omicron variant among healthcare workers (HCWs) remain unclear. Methods A cross-sectional study was conducted at a hospital in Southern China. The study included 262 HCWs who were infected with SARS-CoV-2 between April and June 2023, with 101 ...
1 day ago · Two doses of Pfizer-BioNTech (BNT162b2) vaccine protected against COVID-19–related hospitalizations before and after emergence of the SARS-CoV-2 Delta variant (2,3). Throughout Omicron variant predominance (beginning in December 2021), estimated pediatric COVID-19 vaccine effectiveness (VE) of the original monovalent vaccine was lower (2,4 ...
Apr 10, 2024 · Currently-circulating omicron SARS-CoV-2 variant and its derivatives led to soaring rates of breakthrough infections due to the high density of mutations in the spike protein facilitating immune ...
Apr 4, 2024 · The Omicron BA.2 variant has already caused another rise in COVID cases in Europe. The U.S. Centers for Disease Control and Prevention estimates about 4% of Americans with COVID now have ...
2 days ago · Objective This study aims to analyze the molecular characteristics of the novel coronavirus (SARS-CoV-2) Omicron variant BA.2.76 in Jining City, China. Methods Whole-genome sequencing was performed on 87 cases of SARS-CoV-2 infection. Evolutionary trees were constructed using bioinformatics software to analyze sequence homology, variant sites, N-glycosylation sites, and phosphorylation sites ...
